JPH0151779B2 - - Google Patents
Info
- Publication number
- JPH0151779B2 JPH0151779B2 JP56182022A JP18202281A JPH0151779B2 JP H0151779 B2 JPH0151779 B2 JP H0151779B2 JP 56182022 A JP56182022 A JP 56182022A JP 18202281 A JP18202281 A JP 18202281A JP H0151779 B2 JPH0151779 B2 JP H0151779B2
- Authority
- JP
- Japan
- Prior art keywords
- molecular weight
- copolymer
- particles
- peak
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002245 particle Substances 0.000 description 40
- 229920001577 copolymer Polymers 0.000 description 36
- 239000000178 monomer Substances 0.000 description 25
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 20
- 230000007717 exclusion Effects 0.000 description 19
- 239000011148 porous material Substances 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000002209 hydrophobic effect Effects 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 239000000945 filler Substances 0.000 description 14
- 238000004128 high performance liquid chromatography Methods 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 238000012856 packing Methods 0.000 description 13
- 238000000926 separation method Methods 0.000 description 13
- 150000003943 catecholamines Chemical class 0.000 description 12
- 238000007334 copolymerization reaction Methods 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 11
- 238000010557 suspension polymerization reaction Methods 0.000 description 11
- 239000007900 aqueous suspension Substances 0.000 description 10
- 239000003480 eluent Substances 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 239000013060 biological fluid Substances 0.000 description 8
- 108010017384 Blood Proteins Proteins 0.000 description 7
- 102000004506 Blood Proteins Human genes 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- ALLHBGFTFKPCDX-UHFFFAOYSA-N C(C(=C)C)(=O)OC(COC(C(=C)C)=O)CCCCCCCCCCCCCC Chemical compound C(C(=C)C)(=O)OC(COC(C(=C)C)=O)CCCCCCCCCCCCCC ALLHBGFTFKPCDX-UHFFFAOYSA-N 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 239000003613 bile acid Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
- 235000019400 benzoyl peroxide Nutrition 0.000 description 4
- 239000011362 coarse particle Substances 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960002748 norepinephrine Drugs 0.000 description 3
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 2
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229960002695 phenobarbital Drugs 0.000 description 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 2
- 229960001661 ursodiol Drugs 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- IGGDKDTUCAWDAN-UHFFFAOYSA-N 1-vinylnaphthalene Chemical compound C1=CC=C2C(C=C)=CC=CC2=C1 IGGDKDTUCAWDAN-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- LCKPEFUXKRSTMA-UHFFFAOYSA-N 6-propan-2-yl-7-oxabicyclo[4.1.0]hepta-2,4-diene Chemical compound C1=CC=CC2(C(C)C)C1O2 LCKPEFUXKRSTMA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000012883 sequential measurement Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯é«é液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«å€
ã«é¢ãããDETAILED DESCRIPTION OF THE INVENTION The present invention relates to a packing material for high performance liquid chromatography.
èšåºæ€æ»æè¡ã®é²æ©ã«äŒŽãªããè¡æž
ãå°¿ã®ãã
ãªçäœæ¶²äžã®äœååéæåãåé¢ãã枬å®ããã
ãšãè¡ãªãããŠãããäŸãã°ã«ãã³ãŒã«ã¢ãã³ã
ã°ã¢ããžãååç©ãèæ±é
žããã¿ãã³ãã¹ããã€
ããã«ã¢ã³ãè¬ç©çã®åç»ãè¡ãªãããŠããã With advances in clinical testing technology, low molecular weight components in biological fluids such as serum and urine are being separated and measured. For example, catecholamines,
Fractionation of guanidino compounds, bile acids, vitamins, steroid hormones, drugs, etc. is carried out.
åŸæ¥ã¯ãã®äœååéæåãåé¢ããæ¹æ³ãšã
ãŠãããªã¯ãã«é
¢é
žãéå¡©çŽ é
žçãçšããŠé«åå
éã®èçœè³ªãé€ããæŽã«å€Ÿéç©ã®åœ±é¿ãé€ããã
ã«é©åœãªååŠçãè¡ãªã€ãåŸãé«é液äœã¯ããã
ã°ã©ãã€ãŒã§åé¢ãå®éãè¡ãªãããšãå€ããã
ããé«ååéã®èçœè³ªãé€å»ããæäœãçç¥ã
ãŠããã®ãŸãè¡æž
ãããã¯å°¿çã®çäœæ¶²ãé«é液
äœã¯ãããã°ã©ãã€ãŒçšã«ã©ã ã«å°å
¥ãããšå¹
åº
ãèçœè³ªã®ããŒã¯ãäœååéæåã®ããŒã¯ã«éãª
ããäœååéæåã®åé¢å®éãã§ããªããªã€ã
ããå
å¡«å€ã«èçœè³ªãäžå¯éåžçããŠå
å¡«å€ã®å¯¿
åœãçãããªããåäœååéæåã®åé¢æåãå€
ã€ããããã Conventionally, the method for separating low-molecular weight components is to remove high-molecular weight proteins using trichloroacetic acid, perchloric acid, etc., and then perform appropriate pretreatment to remove the effects of impurities. Separation and quantification are often performed by chromatography. However, when biological fluids such as serum or urine are directly introduced into a high-performance liquid chromatography column without the step of removing high-molecular-weight proteins, the broad protein peaks overlap with the low-molecular-weight component peaks. It may become impossible to separate and quantify the components, the life of the packing material may be shortened due to irreversible adsorption of proteins to the packing material, or the separation behavior of low molecular weight components may change.
ãã®ããåŸæ¥ã®é«é液äœã¯ãããã°ã©ãã€ãŒã§
ã¯é€èçœæäœã¯ãçç¥ã§ããªããã®ãšãããŠã
ããããããªããé€èçœæäœã«ã¯é å¿åé¢ã20å
以äžãïŒåç¹°è¿ãå¿
èŠããããæäœãç¹éã§æé
ãããããããæ¬ ç¹ããã€ããæŽã«é€èçœæäœã«
ãããèçœè³ªãæ²æ®¿ãšããŠåé€ãéã«ãäœååé
æåããã®æ²æ®¿å
ã«å蟌ãŸããååçãäœäžãã
ããæ¬ ç¹ããã€ããç¹ã«äœååéæåã¯æ¥µããŠåŸ®
éã«ããå«ãŸããŠããªãããšãå€ããé€èçœæäœ
ã«ãã€ãŠååçãäœäžããæ€åºãã®ãã®ãã§ããª
ããªã€ãã枬å®ç²ŸåºŠãæªããªã€ããããŠããã For this reason, in conventional high-performance liquid chromatography, the protein removal operation has been considered indispensable. However, the protein removal procedure required repeating centrifugation twice for 20 minutes or more, which had the disadvantage that the procedure was complicated and took too much time. Furthermore, when protein is removed as a precipitate by the protein removal operation, low molecular weight components are incorporated into the precipitate, resulting in a disadvantage that the recovery rate tends to decrease. In particular, low-molecular-weight components are often contained in extremely small amounts, and the recovery rate decreases when the protein is removed, making detection impossible or reducing measurement accuracy.
æ¬çºæã¯ããããé€èçœæäœãçç¥ããããã
äœååéæåã®åé¢å®éãã§ããé«é液äœã¯ãã
ãã°ã©ãã€ãŒçšå
å¡«å€ãæäŸããããšãç®çãšã
ãã The object of the present invention is to provide a packing material for high-performance liquid chromatography that can omit such a protein removal operation and allow the separation and quantification of low molecular weight components.
æ¬çºæã®èŠæšã¯ãããšãã«åºãæããããã«ç³»
åéäœããéžã°ããçæ°Žæ§åéäœãšã
ïŒåŒäžãã¯ïŒšåã¯CH3ãïœã¯ïŒä»¥äžã®æŽæ°ãè¡š
ããïŒãβâãã€ãããã·ãšãã«ã¡ã¿ã¢ã¯ãªã¬ãŒã
ããã³ã¢ã¯ãªã«ã¢ãããããªã矀ã®äžããéžã°ã
ãïŒçš®åã¯ïŒçš®ä»¥äžã®èŠªæ°Žæ§åéäœãšã®å
±éåã«
ãã€ãŠåŸãããå
±éåäœã«ãããçæ°Žæ§åéäœã®
å
±éåæåéã40ã95ééïŒ
ã§ããã芪氎æ§åé
äœã®å
±éåæåéã60ãïŒéåïŒ
ã§ããããã€æº¶
解床ãã©ã¡ãŒã¿ãŒïŒSPå€ïŒã8.4以äžã§ããå
±é
åäœãããªãå€åæ§ç²åã§ãã€ãŠãæé€éçå€
ïŒPLå€ïŒPermeation LimitïŒã2000ã60000ã®ç¯
å²å
ã«åãããã®ã§ããããšãç¹åŸŽãšãããé«é
液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«å€ã«åããã The gist of the present invention is a hydrophobic monomer selected from vinyl monomers having a phenyl group, (In the formula, R represents H or CH 3 and n represents an integer of 2 or more), one or more hydrophilic monomers selected from the group consisting of β-hydroxyethyl methacrylate and acrylamide. The copolymerization amount of the hydrophobic monomer in the copolymer is 40 to 95% by weight, and the copolymerization amount of the hydrophilic monomer is 60 to 5% by weight. and porous particles made of a copolymer with a solubility parameter (SP value) of 8.4 or more, and the exclusion limit value (PL value: Permeation Limit) is within the range of 2000 to 60000. A packing material for high performance liquid chromatography, characterized by:
次ã«æ¬çºæé«é液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«
å€ã«ã€ããŠæŽã«è©³çŽ°ã«èª¬æããã Next, the packing material for high performance liquid chromatography of the present invention will be explained in more detail.
æ¬çºæã«ãããé«é液äœã¯ãããã°ã©ãã€ãŒçš
å
å¡«å€ã¯ãçæ°Žæ§åéäœãšèŠªæ°Žæ§åéäœãšã®å
±é
åäœãããªããçæ°Žæ§åéäœãå
±éåæåãšãã
ãããšã«ãã€ãŠã液äœã¯ãããã°ã©ãã€ãŒã«éã
çæ°Žæ§éšåãæããäœååç©è³ªã«å¯Ÿããåé¢èœã
ä»äžãããããšã«ãªããå芪氎æ§åéäœãå
±éå
æåãšãããããšã«ãã€ãŠã氎系溶é¢æ¶²ãçšãã
åé¢ãå¯èœãšãªããçæ°Žæ§åéäœãšããŠã¯ãããš
ãã«åºãæããããã«ç³»åéäœã䜿çšããããäŸ
ãã°ã¹ãã¬ã³ããšãã«ã¹ãã¬ã³ããžããã«ãã³ãŒ
ã³ãããã«ãã«ãšã³ãããã«ããã¿ã¬ã³ãâã
ãã«ã«ã«ããŸãŒã«çã䜿çšãããã The packing material for high performance liquid chromatography in the present invention is made of a copolymer of a hydrophobic monomer and a hydrophilic monomer. By using a hydrophobic monomer as a copolymerization component, separation ability for low-molecular substances having a hydrophobic portion is imparted during liquid chromatography, and the hydrophilic monomer is also used as a copolymerization component. By using it as a component, separation using an aqueous eluent becomes possible. As the hydrophobic monomer, a vinyl monomer having a phenyl group is used. For example, styrene, ethylstyrene, divinylbenzene, vinyltoluene, vinylnaphthalene, N-vinylcarbazole, etc. are used.
ããã¯ã«ãã³ãŒã«ã¢ãã³ãããšãã«ã¢ã©ãã³ã
ããã·ã³çã®è³éŠæã¢ããé
žçã®è³éŠæ系氎溶æ§
ç©è³ªãåé¢ããããã«ã¯ãè³éŠæ系氎溶æ§ç©è³ªã®
ããšãã«åºãšã®çžäºäœçšãæããããšã奜ãŸãã
ããã§ããã These are catecholamines, phenylalanine,
This is because in order to separate an aromatic water-soluble substance such as an aromatic amino acid such as tyrosine, it is preferable to have an interaction with the phenyl group of the aromatic water-soluble substance.
芪氎æ§åéäœãšããŠã¯ã
ïŒåŒäžãã¯ïŒšåã¯CH3ãïœã¯ïŒä»¥äžã®æŽæ°ãè¡š
ããïŒãβâãã€ãããã·ãšãã«ã¡ã¿ã¢ã¯ãªã¬ãŒã
ããã³ã¢ã¯ãªã«ã¢ãããããªã矀ã®äžããéžã°ã
ãïŒçš®åã¯ïŒçš®ä»¥äžã®ãã®ã䜿çšãããã As a hydrophilic monomer, (In the formula, R represents H or CH 3 , and n represents an integer of 2 or more.) One or more selected from the group consisting of β-hydroxyethyl methacrylate and acrylamide are used. Ru.
ãšããŠã¯ãäŸãã°ããžãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿
ã¢ã¯ãªã¬ãŒããããã©ãã·ã«ãšãã¬ã³ã°ãªã³ãŒã«
ãžã¡ã¿ã¢ã¯ãªã¬ãŒããããªãšãã¬ã³ã°ãªã³ãŒã«ãž
ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãçã䜿çšãããã For example, diethylene glycol dimethacrylate, tetradecylethylene glycol dimethacrylate, polyethylene glycol di(meth)acrylate, etc. are used.
å
±éåäœã«ãããçæ°Žæ§åéäœã®å
±éåæåé
ã40ã95ééïŒ
ã§ãã€ãŠã芪氎æ§ã®åéäœã®å
±é
åæåéã¯60ãïŒééïŒ
ãšããããçæ°Žæ§åéäœ
ã®å
±éåæåéã95ïŒ
ãããå€éã§ãã€ãŠèŠªæ°Žæ§
åéäœã®å
±éåæåéãïŒééïŒ
ãããå°éã§ã
ããšãå
±éåäœã¯æ°Žã«å¯ŸããæŒããæªããªããæ°Ž
系溶é¢æ¶²ããã®çäœæ¶²äžã®äœååéæåã®åé¢ã
ãé£ããªããåãçæ°Žæ§åéäœã®å
±éåæåéã
40ééïŒ
ãããå°éã§ãã€ãŠèŠªæ°Žæ§åéäœã®å
±é
åæåéã60ééïŒ
ãããå€éã«ãªããšãå
±éå
äœã¯çæ°Žæ§éšåãæããäœååéæåã«å¯Ÿããå
é¢èœãäœããã®ãšãªãã The amount of the hydrophobic monomer in the copolymer is 40 to 95% by weight, and the amount of the hydrophilic monomer is 60 to 5% by weight. If the amount of copolymerized hydrophobic monomer is more than 95% and the amount of copolymerized hydrophilic monomer is less than 5% by weight, the copolymer will have poor leakage to water. , it becomes difficult to separate low molecular weight components in biological fluids from aqueous eluents. In addition, the amount of copolymerization of hydrophobic monomer is
If the copolymerized amount of the hydrophilic monomer is less than 40% by weight and greater than 60% by weight, the copolymer will have a low separation ability for low molecular weight components having hydrophobic portions.
åãå
±éåäœã®æº¶è§£åºŠãã©ã¡ãŒã¿ãŒã¯8.4以äž
ã®ãã®ã䜿çšããããããã¯å
±éåäœã®æ°Žç³»æº¶é¢
液äžã§ã®æŒããããããããã§ãããå
±éåäœã®
溶解床ãã©ã¡ãŒã¿ãŒã8.4ãããå°ãããªããšã
å
±éåäœã¯æ°Žã«å¯ŸããæŒããæªããªãã氎系溶é¢
液ããã®çäœæ¶²äžã®äœååéæåã®åé¢ã«é©ããª
ããã®ãšãªãã Further, the solubility parameter of the copolymer used is 8.4 or more. This is to improve leakage of the copolymer in the aqueous eluent. When the solubility parameter of the copolymer is less than 8.4,
Copolymers have poor leakage to water, making them unsuitable for separating low molecular weight components in biological fluids from aqueous eluents.
溶解床ãã©ã¡ãŒã¿ãŒïŒSPå€ïŒSolubility
ParameterïŒã¯ã芪氎æ§ã®çšåºŠãè¡šããæ°å€ã§ã
ã€ãŠãå¯åºŠïŒÏïŒãååéïŒïŒïŒãåéãšãã«ã®ãŒ
å®æ°(G)ãã次ã®åŒã«ãã€ãŠæ±ããããã Solubility parameter (SP value: Solubility
Parameter) is a numerical value representing the degree of hydrophilicity, and is determined from the density (Ï), molecular weight (M), and cohesive energy constant (G) using the following formula.
SPïŒÏΣGïŒïŒ
äŸãã°èŠªæ°Žæ§åéäœã次åŒã
ã§è¡šããããç©è³ªã§ãïŒCH3ãïœïŒ14ã®å Žåã¯
ããã©ã·ã«ãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¢ã¯ãªã¬ãŒ
ãã§ãããã溶解床ãã©ã¡ãŒã¿ãŒã16.9ã§ããã
çæ°Žæ§åéäœããžããã«ãã³ãŒã³ã®å Žåã¯æº¶è§£åºŠ
ãã©ã¡ãŒã¿ãŒã8.0ã§ãããå
±éåäœæåãšããŠ
ããã©ãã·ã«ãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¢ã¯ãªã¬
ãŒãã5.0ééïŒ
å«æããå
±éåäœã®æº¶è§£åºŠãã©
ã¡ãŒã¿ãŒã8.4ãšãªããæ°Žã«æŒããçšåºŠã®èŠªæ°Žæ§
ãšçäœæ¶²äžã®äœååéæåã®åé¢ã«å
åãªãžãã
ã«ãã³ãŒã³ãå«æãããã®ãšãªãã SP=ÏΣG/M For example, the hydrophilic monomer has the following formula: In the case of R = CH 3 and n = 14, it is tetracylethylene glycol dimethacrylate, but the solubility parameter is 16.9,
When the hydrophobic monomer is divinylbenzene, the solubility parameter is 8.0, and the solubility parameter of a copolymer containing 5.0% by weight of tetradecyl ethylene glycol dimethacrylate as a copolymer component is 8.4, which is the extent to which it leaks into water. It contains sufficient divinylbenzene for hydrophilicity and separation of low molecular weight components in biological fluids.
æ¬çºæé«é液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«å€
ã¯ãå€åæ§ã®ç²åã§ãããç²ååŸã¯ïŒã40ÎŒïœã®
ç¯å²ã«åãããã®ãšãããããšã«ãããé«é液äœ
ã¯ãããã°ã©ãã€ãŒçšå
å¡«å€ãšããŠå¥œé©ãªãã®ãš
ãªããç²ååŸããã®ç¯å²å
ã«ããããã«æã€ãã
ã®ãšãªãã«ã¯ãæ°Žæ§æžæ¿éåã«ããå
±éåäœãåŸ
ããã®ãæŽã«å¿
èŠã«å¿ãåçŽããããšã«ãããªã
ãããå现åã¯ç²ååŸã«ããç°ãªããäžè¬ã«ç²å
ã®ç¯å²ã®å
éšã«åã€ãŠ50ã2000Aãã®ç¯å²å
ã«å
ããã®ã奜ãŸããã The high-performance liquid chromatography filler of the present invention is a porous particle with a particle size in the range of 3 to 40 ÎŒm, making it suitable as a high-performance liquid chromatography filler. . The particle size can be made uniform within this range by further classifying the copolymer obtained by aqueous suspension polymerization, if necessary. Although the pores vary depending on the particle size, it is generally preferable that the pores exist within a range of 50 to 2000 A° toward the inside of the particle.
ç²åå
ã®çŽ°å容éã¯ç²å容éã®ïŒã50ïŒ
ãå ã
ããã®ãšãããã®ã奜é©ã§ããããã®å Žåã«ã¯ç²
åå
è¡šé¢ç©ãå¢å ããçäœæ¶²äžã®äœååéæåãš
å
±éåäœã®çæ°Žæ§çžäºäœçšã倧ãããªãããã®çµ
æäœååéæåã®åé¢ããããªããããããªãã
现å容éãç²å容éã®50ïŒ
ããã倧ãããªããšã
ç²åãè»ãããªããããŠèšæœ€ãåçž®ãçãããã
ãããããåïŒïŒ
ãããå°ãªããªããšäœååéæ
åãšå
±éåäœãšã®çæ°Žæ§çžäºäœçšãäœäžããäœå
åéæåã®åé¢ãå
åã«ã§ããªããã®ãšãªããã
ãã Preferably, the pore volume within the particles accounts for 5 to 50% of the particle volume. In this case, the internal surface area of the particles increases, and the hydrophobic interaction between the copolymer and the low molecular weight components in the biological fluid increases, resulting in improved separation of the low molecular weight components. However, when the pore volume becomes larger than 50% of the particle volume,
Particles may become too soft, causing swelling and contraction, and if the amount is less than 5%, the hydrophobic interaction between the low molecular weight component and the copolymer will decrease, making it impossible to separate the low molecular weight component sufficiently. It's easy to become.
ç²åå
ã®çŽ°å容éã®æž¬å®ã¯ãæ°Žéå§å
¥æ³ãé©çš
ããŠè¡ãªãããšãã§ãããã€ã©ãã¡ãŒã¿ãŒäžã®è©Š
æã«ç空ç¶æ
ã§æ°Žéãå«æµžããã®ã¡ãå§å容åšäž
ã§å§åãããè©Šæäžãžã®æ°Žéã®äŸµå
¥ã«ããäœç©æž
å°ã枬å®ããŠæ±ããããšãã§ãããã®çŽ°å容éã
ç²å容éã«å¯Ÿããå²åã§è¡šç€ºããã The pore volume within particles can be measured by applying mercury intrusion method, in which a sample in a dilatometer is impregnated with mercury in a vacuum state, and then pressure is applied in a pressure vessel to inject mercury into the sample. This can be determined by measuring the volume reduction due to the intrusion of particles, and this pore volume is expressed as a percentage of the particle volume.
ç²åã®çŽ°å容éã®èª¿æŽã¯ãæ°Žæ§æžæ¿éåã«ãã
å
å¡«å€ç²åãåŸãã«éããææ©æº¶åªã®çš®é¡ãçµå
ãã䜿çšéçãå€ããããšã«ãããªãããã The pore volume of particles can be adjusted by changing the type, combination, amount used, etc. of organic solvents when obtaining filler particles by aqueous suspension polymerization.
æ¬çºæã«ãããé«é液äœã¯ãããã°ã©ãã€ãŒçš
å
å¡«å€ã¯ãæé€éçå€ïŒPLå€ïŒã2000ã60000ã®
ç¯å²å
ã«åãããã®ãšãããã The packing material for high performance liquid chromatography in the present invention has an exclusion limit value (PL value) within a range of 2,000 to 60,000.
æé€éçå€ãšã¯ãæšæºè©ŠæãšããŠããªã¹ãã¬ã³
ã®ããã©ããããã©ã³æº¶æ¶²ãçšãã溶é¢æ¶²ãšããŠ
ããã©ããããã©ã³ã䜿çšãã液äœã¯ãããã°ã©
ãã€ãŒã«ãããéã«ãå
å¡«å€ç²åã®çŽ°åã«å
¥ã蟌
ãŸãªããã®ãšãªãåèšæšæºè©Šæã®ååéãããã
ãããŠãã®æé€éçå€ã¯ãæèšããã°ãå
å¡«å€ç²
åãæãã现åã®å€§ãããæšæºè©Šæãšãªãããªã¹
ãã¬ã³ã®ååéã®å€§ããã«æç®ããŠè¡šçŸãããã®
ã§ããã The exclusion limit value is the molecular weight of the standard sample that does not enter the pores of the filler particles when it is subjected to liquid chromatography using a tetrahydrofuran solution of polystyrene as the standard sample and tetrahydrofuran as the eluent. means.
In other words, this exclusion limit value is expressed by converting the size of the pores of the filler particles into the size of the molecular weight of polystyrene serving as a standard sample.
æé€éçå€ã®æž¬å®ã«ã¯ãååéãããã€ãŠãã
ãããçš®ã
çžéããããªã¹ãã¬ã³ã®ããã©ããã
ãã©ã³æº¶æ¶²ãçšãã溶é¢æ¶²ãšããŠããã©ãããã
ã©ã³ã䜿çšãã液äœã¯ãããã°ã©ãã€ãŒã«ãããŠ
å
å¡«å€ç²åã®çŽ°åã«ä¿æãããªããã®ãšãªãããª
ã¹ãã¬ã³ã®ååéãæ±ããã°ãããå
å¡«å€ã®æé€
éçå€ã2000ã60000ã®ç¯å²å
ã«åãããã®ãšã
ããã®ã¯ãçäœæ¶²äžã®èçœè³ªæåã¯ãã¢ã«ããã³
ïŒååé6.5äžïŒãç³èçœïŒååéïŒäžã30äžïŒããª
ãèçœïŒååé30äžã300äžïŒãè£äœïŒååéïŒäž
ã40äžïŒãå
ç«ã°ãããªã³ïŒååé10äžã100äžïŒã
ãã€ããªããŒã²ã³ïŒååé34äžïŒçã§ããããã
ãã¯å
å¡«å€ã®æé€éçå€ãïŒäžãããå°ãããã
ããšã«ãã€ãŠç²åã®çŽ°åã«å
¥ã蟌ãŸãªããã®ãšã
ãããšãã§ããåäœååéæåã¯ã«ãã³ãŒã«ã¢ã
ã³ïŒååé150ïŒãã°ã¢ããžãååç©ïŒååé100
ã300ïŒãã¢ããé
žïŒååé100ã300ïŒããã¿ãã³
ïŒååé250ã1300ïŒçã§ããããããã¯å
å¡«å€ã®
æé€éçå€ã2000ããã倧ããããããšã«ãã€ãŠ
ç²åã®çŽ°åã«ä¿æããããã®ãšããããšãã§ãã
ããã§ãããæé€éçå€ã2000ã60000ã®ç¯å²å
ã«åãããã®ãšãããããšã«ãã€ãŠãå
å¡«å€ã®ç²
åã®åã«èçœè³ªã¯ä¿æãããã现åå€ãéã€ãŠæ©
ã溶åºããäœååéæåã¯çŽ°åã«ããä¿æããã
ããèçœè³ªãããé
ããŠæº¶åºããããåäœååé
æåéã§ã¯çæ°Žæ§ã®éãã«ããåé¢ããªãããã To measure the exclusion limit value, we used tetrahydrofuran solutions of polystyrenes with different molecular weights, used tetrahydrofuran as the eluent, and applied liquid chromatography to obtain polystyrenes that would not be retained in the pores of the filler particles. All you have to do is find the molecular weight of The exclusion limit value of the filler is considered to be within the range of 2,000 to 60,000 because protein components in biological fluids include albumin (molecular weight 65,000), glycoprotein (molecular weight 50,000 to 300,000), and lipoprotein. (molecular weight 300,000 to 3 million), complement (molecular weight 70,000 to 400,000), immunoglobulin (molecular weight 100,000 to 1 million),
Fibrinogen (molecular weight: 340,000), etc., can be prevented from entering the pores of particles by setting the exclusion limit of the filler to less than 60,000, and low molecular weight components include catecholamines (molecular weight: 340,000). molecular weight 150), guanidino compounds (molecular weight 100
-300), amino acids (molecular weight 100-300), vitamins (molecular weight 250-1300), etc., which can be retained in the pores of particles by increasing the exclusion limit of the filler to more than 2000. This is because it can be done. By setting the exclusion limit value to be within the range of 2,000 to 60,000, proteins are not retained in the pores of the filler particles, but elute quickly through the outside of the pores, and low molecular weight components are absorbed into the pores. Because it is retained by protein, it elutes later than protein. Furthermore, low molecular weight components are separated due to differences in hydrophobicity.
æ¬çºæé«é液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«å€
ã¯ãçæ°Žæ§åéäœãšèŠªæ°Žæ§åéäœãæžæ¿éåãã
ãããšã«ããåŸãããããæ°Žæ§æžæ¿éåãè¡ãªã
ããã«ã¯ãçæ°Žæ§åéäœãšèŠªæ°Žæ§åéäœã®æ··åç©
ã溶解ããããå
±éåäœã溶解ããªãææ©æº¶åªã®
ååšäžã«å
±éååå¿ãè¡ãªããããäžèšææ©æº¶åª
ãšããŠã¯äŸãã°ãã«ãšã³ããã·ã¬ã³ããžãšãã«ã
ã³ãŒã³ãããã·ã«ãã³ãŒã³çã®è³éŠæçåæ°ŽçŽ
é¡ããããµã³ãããã¿ã³ããªã¯ã¿ã³ããã«ã³çã®
飜åçåæ°ŽçŽ é¡ãã€ãœã¢ãã«ã¢ã«ã³ãŒã«ãããã·
ã«ã¢ã«ã³ãŒã«ããªã¯ãã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒ
ã«é¡ããããããã The packing material for high performance liquid chromatography of the present invention can be obtained by suspension polymerization of a hydrophobic monomer and a hydrophilic monomer. The copolymerization reaction is carried out in the presence of an organic solvent that dissolves the mixture of hydrophilic monomers but does not dissolve the copolymer. Examples of the organic solvent include aromatic hydrocarbons such as toluene, xylene, diethylbenzene, and dodecylbenzene, saturated hydrocarbons such as hexane, heptane, octane, and decane, and alcohols such as isoamyl alcohol, hexyl alcohol, and octyl alcohol. It will be done.
ææ©æº¶åªã«ããåèšæ··åç©ã¯åäžã«æº¶è§£ãã
ãŠãåèšæ··åç©ãæ°Žæ§æžæ¿éåãããã®ã§ãåŸã
ããéåäœç²åäžã«ææ©æº¶åªãåæ£ããŠååšããŠ
ãããéåçµäºåŸäžèšææ©æº¶åªãç²åäžããåã
é€ãããšã«ããå€åæ§ã§çç¶ã®å
±éåäœãåŸãã
ãã Since the mixture is uniformly dissolved by the organic solvent and the mixture is subjected to aqueous suspension polymerization, the organic solvent is dispersed in the obtained polymer particles, and after the polymerization is completed, the organic solvent is added to the particles. By removing it from the inside, a porous and spherical copolymer is obtained.
åæ°Žæ§æžæ¿éåã¯ãããšãã°åèšææ©æº¶åªã«ã
åèšæ··åç©åã³ã©ãžã«ã«çºç觊åªã溶解ããåŸã
ãã溶液ãããªããã«ã¢ã«ã³ãŒã«ããªã³é
žã«ã«ã·
ãŠã çã®æžæ¿éåå®å®å€ã®åæ£ãããæ°Žçžã«æ·»å
ãæ¹æããªãã50ã100âã«å ç±ããããšã«ãã
è¡ãªãããã In addition, in aqueous suspension polymerization, for example, in the organic solvent,
This is carried out by dissolving the mixture and the radical generating catalyst, adding the resulting solution to an aqueous phase in which a suspension polymerization stabilizer such as polyvinyl alcohol and calcium phosphate is dispersed, and heating the mixture to 50 to 100° C. with stirring.
äžèšã©ãžã«ã«çºç觊åªã¯åå¿éå§å€ãšããŠã©ãž
ã«ã«ãçºçãã觊åªã§ãããã該觊åªãšããŠã¯ã
ãšãã°ãã³ãŸã€ã«ããŒãªããµã€ããã¯ã¡ã³ããŒãª
ããµã€ãçã®ææ©éé
žåç©ãéé
žåæ°ŽçŽ ãéç¡«é
ž
ã«ãªãŠã ãéç¡«é
žã¢ã³ã¢ããŠã çã®ç¡æ©éé
žå
ç©ãã¢ãŸãã¹ã€ãœããããããªã«ãã¢ãŸãã¹ã€ãœ
ãããã¢ããçã®ã¢ãŸååç©ãªã©å
¬ç¥ã®ä»»æã®ã©
ãžã«ã«çºç觊åªã䜿çšãããã The above radical generating catalyst is a catalyst that generates radicals as a reaction initiator. Examples of the catalyst include organic peroxides such as benzoyl peroxide and cumene oxide, and inorganic peroxides such as hydrogen peroxide, potassium persulfate, and ammonium persulfate. Any known radical generating catalyst can be used, such as peroxide, azo compounds such as azobisisobutyronitrile, and azobisisobutyramide.
äžèšæ°Žæ§æžæ¿éåã«ãã€ãŠéåãããå
±éåäœ
ç²åã¯å ç±çã«ãã也ç¥ãããç²åäžã®ææ©æº¶åª
ãæŸåºãããããšã«ãã€ãŠå€åæ§ã§çç¶ã®å
±éå
äœãšãªãããé«é液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«
å€ãšãªãããã®ã§ããã The copolymer particles polymerized by the above-mentioned aqueous suspension polymerization are made into porous and spherical copolymers by releasing the organic solvent in the dried particles by heating, etc. It is used as a filler for e.g.
æé€éçå€ã®èª¿æŽãè¡ãªãã«ã¯ãæ°Žæ§æžæ¿éå
ã«ããçæ°Žæ§åéäœãšèŠªæ°Žæ§åéäœãå
±éåãã
ãã«éããå
±éåäœã®æº¶è§£åºŠãã©ã¡ãŒã¿ãŒãšè¿äŒŒ
ãã溶解床ãã©ã¡ãŒã¿ãŒã®ææ©æº¶åªã䜿çšããã
ãšã«ãããªããããäŸãã°ããã©ãã·ã«ãšãã¬ã³
ã°ãªã³ãŒã«ãžã¡ã¿ã¢ã¯ãªã¬ãŒãã®å
±éåæåéã
5.0ééïŒ
ã§ãããåãžããã«ãã³ãŒã³ã®å
±éå
æåéã95.0ééïŒ
ã§ããå
±éåäœã®æº¶è§£åºŠãã©
ã¡ãŒã¿ãŒã¯8.4ã§ããããããã§ææ©æº¶åªãšããŠ
溶解床ãã©ã¡ãŒã¿ãŒã8.9ã§ãããã«ãšã³ãéžæ
ãŠæ°Žæ§æžæ¿éåãè¡ãªããšãæé€éçå€ã10000
ã®å
å¡«å€ç²åãåŸãããšãã§ããã To adjust the exclusion limit value, when copolymerizing a hydrophobic monomer and a hydrophilic monomer by aqueous suspension polymerization, use an organic solvent with a solubility parameter similar to that of the copolymer. This can be done by For example, the amount of copolymerization of tetradecyl ethylene glycol dimethacrylate is
The solubility parameter of a copolymer containing 5.0% by weight and 95.0% by weight of divinylbenzene is 8.4. Here, toluene with a solubility parameter of 8.9 is selected as the organic solvent to perform an aqueous suspension. When polymerization is performed, the exclusion limit value is 10000
filler particles can be obtained.
æ¬çºæé«é液äœã¯ãããã°ã©ãã€ãŒçšå
å¡«å€ã«
ããã°ãè¡æž
ãå°¿çã®çäœæ¶²äžã®ã«ãã³ãŒã«ã¢ã
ã³ãã°ã¢ããžãååç©ãèæ±é
žããã¿ãã³ãã¹ã
ãã€ããã«ã¢ã³ãè¬ç©çã®äœååéæåãèçœè³ª
çã®é«ååæåããåé¢ãå®éããæ§èœãããã
ãŠãããé€èçœæäœãçç¥ããããšã«ããæäœæ
éãççž®ããããšãã§ããã According to the packing material for high performance liquid chromatography of the present invention, low molecular weight components such as catecholamines, guanidino compounds, bile acids, vitamins, steroid hormones, and drugs in biological fluids such as serum and urine can be separated from high molecular weight components such as proteins. It has excellent separation and quantitative performance, and can shorten operation time by omitting the protein removal operation.
次ã«æ¬çºæã®å®æœäŸãèšãã Next, examples of the present invention will be described.
å®æœäŸ ïŒ
å·åŽåšãæ¹æåšã枩床èšããã³æ»ŽäžããŒãã®èš
眮ãããïŒã»ãã©ãã«ãã©ã¹ã³ã«ïŒééïŒ
ã®ã
ãªããã«ã¢ã«ã³ãŒã«æ°Žæº¶æ¶²400mlãšããã©ãã·ã«
ãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¢ã¯ãªã¬ãŒã10ïœããž
ããã«ãã³ãŒã³90ïœããã«ãšã³100ïœããã³ãã³
ãŸã€ã«ããŒãªããµã€ã1.5ïœãããªãæ··å液ãäŸ
絊ããã次ã«400rpmã®æ¹æé床ã§æ¹æããªãã
80âã«ææž©ã10æééååå¿ãè¡ã€ãŠå·åŽããã
å·åŽåŸéåçæç©ãæ¯æ¶²åé¢ããåŸãç±æ°Žåã³ã¢
ã»ãã³ã§æŽæµããŠç²ååŸãïŒã13ÎŒïœã®å€åæ§ã§
çç¶ã®å
±éåäœãåŸããExample 1 400 ml of 4% by weight aqueous polyvinyl alcohol solution, 10 g of tetradecyl ethylene glycol dimethacrylate, 90 g of dihinylbenzene, 100 g of toluene, and benzoyl peroxide were placed in a two-separable flask equipped with a condenser, stirrer, thermometer, and dropping funnel. A mixture consisting of 1.5 g was fed. Next, while stirring at a stirring speed of 400 rpm.
The temperature was raised to 80°C, a polymerization reaction was carried out for 10 hours, and the mixture was cooled.
After cooling, the polymerization product was separated from the mother liquor and washed with hot water and acetone to obtain a porous, spherical copolymer with a particle size of 5 to 13 ÎŒm.
åŸãããå€åæ§ã§çç¶ã®å
±éåäœã®ãã¡ã埮ç²
ååã³ç²ç²åãåé€ããŠç²ååŸïŒã10ÎŒïœã®ç¯å²
ã®ãã®ã䜿çšããããã®å
±éåäœã®å
±éåæåé
ã¯ããã©ãžã·ã«ãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¢ã¯ãª
ã¬ãŒãã10ééïŒ
ã§ããããžããã«ãã³ãŒã³ã®å
±
éåæåéã90ééïŒ
ã§ãã€ãã Among the porous and spherical copolymers obtained, fine particles and coarse particles were removed, and those having particle diameters in the range of 8 to 10 ÎŒm were used. The amount of copolymerization of this copolymer was 10% by weight of tetradisyl ethylene glycol dimethacrylate and 90% by weight of divinylbenzene.
åãå
±éåäœã®æº¶è§£åºŠãã©ã¡ãŒã¿ãŒã¯8.9ã§ã
ããç²åå
ã®çŽ°å容éã¯ç²å容éã®35ïŒ
ãå ãã
ãã®ã§ãã€ãã Further, the solubility parameter of the copolymer was 8.9, and the pore volume within the particles accounted for 35% of the particle volume.
ããããŠåŸãããå
å¡«å€40mlã120mlã®ããã©
ããããã©ã³ïŒããŒã¯ãã«ãšãã¬ã³ïŒïŒïŒïŒïŒæ··
å液ã«åæ£ããã¹ãã³ã¬ã¹ã«ã©ã ïŒçŽåŸ7.9mmã
é·ã50cmïŒã«é«å§å®æµéãã³ãã«ããããã©ãã
ããã©ã³ïŒããŒã¯ãã«ãšãã¬ã³ïŒïŒïŒïŒïŒã®æ··å
液ã§2.5mlïŒåã®é床ã§å§éããŠå
å¡«ããããã®
ããã«ããŠåŸãããã«ã©ã ãé«é液äœã¯ãããã°
ã©ãã«æ¥ç¶ãã溶é¢æ¶²ãšããŠããã©ããããã©ã³
ãçšããæšæºè©ŠæãšããŠããªã¹ãã¬ã³ã䜿çšããŠ
æé€éçå€ãæ±ããçµæ10000ã§ãã€ãã 40 ml of the thus obtained packing material was dispersed in 120 ml of a tetrahydrofuran/barchlorethylene (1/1) mixture, and a stainless steel column (diameter 7.9 mm,
50 cm in length) was filled with a mixed solution of tetrahydrofuran/barchlorethylene (1/1) at a rate of 2.5 ml/min using a high-pressure constant flow pump. The column thus obtained was connected to a high performance liquid chromatograph, and the exclusion limit value was determined to be 10,000 using tetrahydrofuran as the eluent and polystyrene as the standard sample.
åãæ°ŽïŒã¡ã¿ããŒã«ïŒïŒïŒïŒïŒæ··å液ã«åæ£
ããã¹ãã³ã¬ã¹ã«ã©ã ïŒçŽåŸïŒmmãé·ã25cmïŒã«
é«å§å®æµéãã³ãã«ããæ°ŽïŒã¡ã¿ããŒã«ïŒïŒïŒ
ïŒïŒã®æ··å液ã§2.5mlïŒåã®é床ã§å§éããŠå
å¡«
ãããåŸãããã«ã©ã ãé«é液äœã¯ãããã°ã©ã
ã«æ¥ç¶ãã溶é¢æ¶²ãšããŠ0.1Mãªã³é
žäžã«ãªãŠã
氎溶液ïŒPH3.0ïŒïŒã¡ãã«ã¢ã«ã³ãŒã«ïŒïŒïŒïŒïŒ
æ··å液ãçšããè©ŠæãšããŠæšæºã«ãã³ãŒã«ã¢ãã³
ïŒçš®ïŒãã«ã¢ãã¬ããªã³ãã¢ãã¬ããªã³ãããŒã
ãã³ïŒãæ·»å ããæšæºè¡æž
ãçšããŠåé¢ãè¡ãªã€
ãããã®çµæã第ïŒå³ã«ç€ºããP1ã¯è¡æž
èçœã
P2ã¯ã«ãã³ãŒã«ã¢ãã³ã®åžå
床ããŒã¯ã§ããã
è¡æž
èçœã¯åäžããŒã¯ãšããŠæº¶åºããããã®åŸã«
ïŒçš®ã®ã«ãã³ãŒã«ã¢ãã³ãåäžäœçœ®ã«æº¶åºãã
ãã第ïŒå³ã§ã¯ååéåå²èœã®ã¿ã§èçœè³ªãšã«ã
ã³ãŒã«ã¢ãã³ãåé¢ããŠãããããèçœè³ªã¯æé€
éçå€ã®äœçœ®ïŒV0ïŒã«æº¶åºãããåïŒçš®ã®ã«ã
ã³ãŒã«ã¢ãã³ã¯ååéãæ®ãã©åäžã§ããã®ã§ã
åäžäœçœ®ã«æº¶åºãããŠããã In addition, it was dispersed in a water/methanol (1/1) mixture and added to a stainless steel column (diameter 5 mm, length 25 cm) using a high-pressure constant flow pump.
The mixture of 1) was pumped and filled at a rate of 2.5 ml/min. The obtained column was connected to a high performance liquid chromatograph, and the eluent was 0.1M monopotassium phosphate aqueous solution (PH3.0)/methyl alcohol (8/2).
Separation was performed using the mixed solution and standard serum to which three standard catecholamines (noradrenaline, adrenaline, and dopamine) were added as a sample. The results are shown in FIG. P 1 is a serum protein;
P2 is the absorbance peak of catecholamine,
Serum proteins were eluted as a single peak, followed by three catecholamines eluted at the same position. In Figure 1, proteins and catecholamines are separated only by molecular weight resolution, so proteins are eluted at the exclusion limit position (V 0 ), and the three types of catecholamines have almost the same molecular weight, so
Eluted at the same position.
æŽã«äœååéæåã§ããïŒçš®ã®ã«ãã³ãŒã«ã¢ã
ã³ã倫ã
åé¢ããããã«ã溶é¢æ¶²ãšããŠ0.1Mãª
ã³é
žäžã«ãªãŠã 氎溶液ïŒPH3.0ïŒã䜿çšããŠåé¢
ããããã®çµæ第ïŒå³ã«ç€ºãããã«è¡æž
èçœ
ïŒP3ïŒã¯æé€éçå€ã®äœçœ®ïŒV0ïŒã«æº¶åºãããã
ã«ã¢ãã¬ããªã³ïŒP4ïŒãã¢ãã¬ããªã³ïŒP5ïŒãã
ãŒããã³ïŒP6ïŒã¯éçžåé
ã«ãã€ãŠå€«ã
åãã
ãŠæº¶åºãããã Furthermore, in order to separate each of the three types of catecholamines, which are low molecular weight components, a 0.1M monopotassium phosphate aqueous solution (PH3.0) was used as an eluent. As a result, as shown in Figure 2, serum protein (P 3 ) was eluted at the exclusion limit position (V 0 ), and noradrenaline (P 4 ), adrenaline (P 5 ), and dopamine (P 6 ) were eluted in the reverse phase. They were eluted separately.
å®æœäŸ ïŒ
ãžããã«ãã³ãŒã³80ïœãβâãã€ãããã·ãšã
ã«ã¡ã¿ã¢ã¯ãªã¬ãŒã20ïœããã«ãšã³100ïœããã³
ãŸã€ã«ããŒãªããµã€ã1.5ïœãããªãæ··å液ã䜿
çšããå®æœäŸïŒãšåæ§ã«ããŠæ°Žæ§æžæ¿éåãè¡ãª
ãå€åæ§ã®çç¶ã®å
±éåäœãåŸããåŸãããå€å
æ§ã§çç¶ã®å
±éåäœã®ãã¡ã埮ç²ååã³ç²ç²åã
é€ããç²åçµïŒã9ÎŒïœã®ãã®äœ¿çšãããExample 2 Aqueous suspension polymerization was carried out in the same manner as in Example 1 using a mixed solution consisting of 80 g of divinylbenzene, 20 g of β-hydroxyethyl methacrylate, 100 g of toluene, and 1.5 g of benzoyl peroxide to form porous spherical polymers. A polymer was obtained. Among the porous and spherical copolymers obtained, those having a particle diameter of 6 to 9 ÎŒm, excluding fine particles and coarse particles, were used.
ãã®å
±éåäœã®å
±éåæåéã¯ãžããã«ãã³ãŒ
ã³ã80ééïŒ
ã§ãããβâãã€ãããã·ãšãã«ã¡
ã¿ã¢ã¯ãªã¬ãŒãã20ééïŒ
ã§ãã€ãã The copolymerization content of this copolymer was 80% by weight of divinylbenzene and 20% by weight of β-hydroxyethyl methacrylate.
åãå
±éåäœã®æº¶è§£åºŠãã©ã¡ãŒã¿ãŒã¯8.5ã§ã
ããç²åå
ã®çŽ°å容éã¯ç²å容éã®24ïŒ
ãå ãã
ãã®ã§ãã€ãã Further, the solubility parameter of the copolymer was 8.5, and the pore volume within the particles accounted for 24% of the particle volume.
ããããŠåŸãããå
å¡«å€ïŒmlãæ°ŽïŒã¢ã»ããã
ãªã«ïŒïŒïŒïŒïŒæ··å液30mlã«åæ£ãããã¹ãã³ã¬
ã¹ã«ã©ã ïŒçŽåŸïŒmmãé·ã25cmïŒã«é«å§å®æµéã
ã³ãã«ãããæ°ŽïŒã¢ã»ããããªã«ïŒïŒïŒïŒïŒæ··å
液ã2.5mlïŒåã®é床ã§å§éããŠå
å¡«ããã Disperse 6 ml of the thus obtained filler in 30 ml of a water/acetonitrile (1/3) mixture, and add the water/acetonitrile (7/3) mixture to a stainless steel column (diameter 5 mm, length 25 cm) using a high-pressure constant flow pump. was filled by pumping at a rate of 2.5 ml/min.
åŸãããã«ã©ã ãå®æœäŸïŒã«ãããŠäœ¿çšããé«
é液äœã¯ãããã°ã©ãã«æ¥ç¶ããå®æœäŸïŒãšåæ§
ã«ããŠæé€éçå€ãæ±ãããšãã20000ã§ãã€ãã
ãŸã溶é¢æ¶²ãšããŠæ°ŽïŒã¢ã»ããããªã«ïŒïŒïŒïŒïŒ
æ··å液ãçšããè©ŠæãšããŠããŒã«è¡æž
ã«æãŠãã
ãå€ã§ããããšããã«ãã¿ãŒã«ã®ã¡ã¿ããŒã«æº¶æ¶²
ãæ·»å ãããã®ãçšããŠåé¢ãè¡ãªã€ãããã®çµ
æã第ïŒå³ã«ç€ºããP7ã¯è¡æž
èçœã®åžå
床ããŒ
ã¯ã§ãããæé€éçå€ã®äœçœ®ïŒV0ïŒã«æº¶åºããã
P8ã¯ããšããã«ãã¿ãŒã«ã®åžå
床ããŒã¯ã§ããã
è¡æž
èçœãšã¯å®å
šã«åé¢ããã The obtained column was connected to the high performance liquid chromatograph used in Example 1, and the exclusion limit value was determined in the same manner as in Example 1, and was found to be 20,000.
Additionally, water/acetonitrile (7/3) was used as an eluent.
Separation was carried out using a mixture of pooled serum and a methanol solution of phenobarbital, an antiepileptic drug, as a sample. The results are shown in FIG. P 7 is the absorbance peak of serum protein and eluted at the exclusion limit position (V 0 ).
P 8 is the absorbance peak of phenobarbital,
It was completely separated from serum proteins.
å®æœäŸ ïŒ
ãžããã«ãã³ãŒã³90ïœãã¢ã¯ãªã«ã¢ãã10ïœã
ãã«ãšã³100ïœããã³ãŸã€ã«ããŒãªããµã€ã1.5ïœ
ãããªãæ··å液ã䜿çšããå®æœäŸïŒãšåæ§ã«ããŠ
æ°Žæ§æžæ¿éåãè¡ãªãå€åæ§ã§çç¶ã®å
±éåäœã
åŸããExample 3 Divinylbenzene 90g, acrylamide 10g,
100g toluene, 1.5g benzoyl peroxide
Aqueous suspension polymerization was carried out in the same manner as in Example 1 using a mixed solution consisting of the following, to obtain a porous and spherical copolymer.
åŸãããå€åæ§ã§çç¶ã®å
±éåäœã®ãã¡ã埮ç²
ååã³ç²ç²åãé€ããç²ååŸ10ã13ÎŒïœã®ãã®ã
䜿çšããã Among the porous and spherical copolymers obtained, those having a particle size of 10 to 13 ÎŒm, excluding fine particles and coarse particles, were used.
ãã®å
±éåäœã®å
±éåæåéã¯ãžããã«ãã³ãŒ
ã³ã90ééïŒ
ã§ãããã¢ã¯ãªã«ã¢ããã10ééïŒ
ã§ãã€ããåå
±éåäœã®æº¶è§£åºŠãã©ã¡ãŒã¿ãŒã¯
8.7ã§ãããç²åå
ã®çŽ°å容éã¯ç²å容éã®16ïŒ
ãå ãããã®ã§ãã€ãã The copolymerization content of this copolymer is 90% by weight of divinylbenzene and 10% by weight of acrylamide.
It was hot. Also, the solubility parameter of the copolymer is
8.7, and the pore volume within the particle is 16% of the particle volume
This accounted for the majority of the population.
ããããŠåŸãããå
å¡«å€ãæ°ŽïŒã¡ã¿ããŒã«
ïŒïŒïŒïŒïŒã®æ··å液ã«åæ£ãããã¹ãã³ã¬ã¹ã«ã©
ã ïŒçŽåŸïŒmmãé·ã25cmïŒã«é«å§å®éæµãã³ãã«
ãããæ°ŽïŒã¡ã¿ããŒã«ïŒïŒïŒïŒïŒã®æ··å液ã2.5
mlïŒåã®é床ã§å§éããŠå
å¡«ããã The thus obtained packing material was dispersed in a water/methanol (1/1) mixture, and the water/methanol (1/1) mixture was added to a stainless steel column (diameter 5 mm, length 25 cm) using a high-pressure constant flow pump. 2.5 liquid
It was filled by pumping at a rate of ml/min.
åŸãããå
å¡«å€ã®æé€éçå€ãå®æœäŸïŒãšåæ§
ã«ããŠæ±ãããšãã22000ã§ãã€ãã The exclusion limit value of the obtained filler was determined in the same manner as in Example 1 and was found to be 22,000.
åå®æœäŸïŒãšåãé«é液äœã¯ãããã°ã©ãã«ã
ããè©ŠæãšããŠããŒã«è¡æž
ã«æšæºèæ±é
žïŒãŠã«ãœ
ããªãã·ã³ãŒã«é
žãã³ãŒã«é
žãã±ãããªãã·ã³ãŒ
ã«é
žããªãã³ãŒã«é
žïŒã®ãšã¿ããŒã«æº¶æ¶²ãæ·»å ã
ããã®ãçšããŠåé¢ãè¡ãªããèå
å
床èšã§æ€åº
ããããã®çµæã第ïŒå³ã«ç€ºãã In addition, the same high-performance liquid chromatography as in Example 1 was applied to perform separation using pooled serum as a sample to which an ethanol solution of standard bile acids (ursodeoxycholic acid, cholic acid, chenodeoxycholic acid, and lithocholic acid) was added. Detected with a photometer. The results are shown in FIG.
P9ã¯è¡æž
èçœã®èå
床ããŒã¯ã§ãããæé€é
çå€ã®äœçœ®ïŒV0ïŒã«æº¶åºãããP10ã¯ãŠã«ãœããª
ãã·ã³ãŒã«é
žãP11ã¯ã³ãŒã«é
žãP12ã¯ã±ãããªã
ã·ã³ãŒã«é
žãP13ã¯ãªãã³ãŒã«é
žã®èå
床ããŒã¯
ã§ãããïŒçš®ã®èæ±é
žã¯ããããåé¢ããã P 9 is the fluorescence peak of serum protein and eluted at the exclusion limit position (V 0 ). P10 is the fluorescence peak of ursodeoxycholic acid, P11 is cholic acid, P12 is the fluorescence peak of chenodeoxycholic acid, and P13 is the fluorescence peak of lithocholic acid, and the four types of bile acids were separated.
æ¯èŒäŸ ïŒ
å®æœäŸïŒã«ãããŠãã«ãšã³100ïœã®ä»£ãã«ïœâ
ãªã¯ãã«ã¢ã«ã³ãŒã«ã100ïœã䜿çšãã以å€ã¯å®
æœäŸïŒãšåæ§ã«ããŠæ°Žæ§æžæ¿éåãè¡ãªããå€å
æ§ã§çç¶ã®å
±éåäœãåŸããComparative Example 1 In Example 1, instead of 100g of toluene, n-
Aqueous suspension polymerization was carried out in the same manner as in Example 1 except that 100 g of octyl alcohol was used to obtain a porous and spherical copolymer.
åŸãããå€åæ§ã§çç¶ã®å
±éåäœã®ãã¡ã埮ç²
ååã³ç²ç²åãé€ããç²ååŸïŒã10ÎŒïœã®ãã®ã
䜿çšããã Among the porous and spherical copolymers obtained, those having a particle size of 8 to 10 ÎŒm, excluding fine particles and coarse particles, were used.
ãã®å
±éåäœã®å
±éåæåéã¯ããã©ãã·ã«ãš
ãã¬ã³ã°ãªã³ãŒã«ãžã¡ã¿ã¢ã¯ãªã¬ãŒãã10ééïŒ
ã§ããããžããã«ãã³ãŒã³ã®å
±éåæåéã90é
éïŒ
ã§ãã€ããåå
±éåäœã®æº¶è§£åºŠãã©ã¡ãŒã¿ãŒ
ã¯8.9ã§ãããç²åå
ã®çŽ°å容éã¯ç²å容éã®32
ïŒ
ãå ãããã®ã§ãã€ãã The copolymerization content of this copolymer is 10% by weight of tetradecyl ethylene glycol dimethacrylate.
The copolymerization content of divinylbenzene was 90% by weight. The solubility parameter of the copolymer is 8.9, and the pore volume within the particles is 32% of the particle volume.
% of the total.
次ãã§ãã®å
å¡«å€ãå®æœäŸïŒãšåæ§ã«ããŠã¹ã
ã³ã¬ã¹ã«ã©ã ã«å
å¡«ããå®æœäŸïŒãšåæ§ã«ããŠæ
é€éçå€ãæ±ãããšãã400000ã§ãã€ãã Next, this packing material was packed into a stainless steel column in the same manner as in Example 1, and the exclusion limit value was determined in the same manner as in Example 1 and was found to be 400,000.
æŽã«å®æœäŸïŒãšåæ§ã«ããŠæšæºã«ãã³ãŒã«ã¢ã
ã³ãæ·»å ããæšæºè¡æž
ãçšããŠåé¢ãè¡ãªã€ãã
ãã®çµæã第ïŒå³ã«ç€ºããP14ã¯è¡æž
èçœãP15ã¯
ãã«ã¢ãã¬ããªã³ãP16ã¯ã¢ãã¬ããªã³ãP17ã¯ã
ãŒããã³ã®åžå
床ããŒã¯ã§ãããã«ãã³ãŒã«ã¢ã
ã³ã¯å¹
åºãããŒã¯ãšéãªãå®éã§ããªãã€ããã
ã®å¹
åºãããŒã¯éšåãååããŠã¢ã»ããŒãèã§é»
æ°æ³³ååæãè¡ãªã€ãçµæãè¡æž
èçœã§ããγâ
ã°ãããªã³ãæ€åºãããã Furthermore, separation was carried out in the same manner as in Example 1 using standard serum to which standard catecholamines had been added.
The results are shown in FIG. P14 is the absorbance peak of serum protein, P15 is noradrenaline, P16 is adrenaline, and P17 is the absorbance peak of dobamine, but catecholamines overlapped with a broad peak and could not be quantified. As a result of fractionating this broad peak portion and performing electrophoretic analysis on an acetate membrane, we found that serum protein γ-
Globulin was detected.
第ïŒå³ã¯å®æœäŸïŒã«ãããã«ãã³ãŒã«ã¢ãã³æ·»
å æšæºè¡æž
ã®ã¯ãããã°ã©ã ã第ïŒå³ã¯å®æœäŸïŒ
ã«ãããŠãã«ãã³ãŒã«ã¢ãã³ãåé¢ããã¯ããã
ã°ã©ã ã第ïŒå³ã¯å®æœäŸïŒã«ãããæãŠãããå€
æ·»å ããŒã«è¡æž
ã®ã¯ãããã°ã©ã ã第ïŒå³ã¯å®æœ
äŸïŒã«ãããæšæºèæ±é
žæ·»å ããŒã«è¡æž
ã®ã¯ãã
ãã°ã©ã ã第ïŒå³ã¯æ¯èŒäŸïŒã«ãããã«ãã³ãŒã«
ã¢ãã³æ·»å æšæºè¡æž
ã®ã¯ãããã°ã©ã ã§ããã
Figure 1 is a chromatogram of catecholamine-added standard serum in Example 1, Figure 2 is Example 1.
Fig. 3 is a chromatogram of the pooled serum supplemented with anti-epileptic drugs in Example 2, Fig. 4 is the chromatogram of the pooled serum supplemented with standard bile acids in Example 3, and Fig. 5 is a comparison. 1 is a chromatogram of catecholamine-added standard serum in Example 1.
ïŒ å€æåè©Šæã®å®éåæã«éã圢æãããã¹ã
ããŒã¯äœçœ®ãé¢é£æåãåå®ããããŒã¯ã®è¡šé¢ç©
ããã®æåã®éçç®å®ãäžããããŒã¯ã¹ãã¯ãã«
ããã€ãžã¿ã«æŒç®è£
眮ãçšããŠåŠçããæ¹æ³ã«ã
ããŠãåäžæåèŒæ£çšè©Šæã«ããçºçãããæšæº
ããŒã¯ã®ã¹ãã¯ãã«å
ã§ã®è¿äŒŒäœçœ®ãšè¿äŒŒåå€å¹
ãšã«å¯Ÿå¿ããä¿¡å·ã®å¶åŸ¡ã®äžã«ãŠé 次äžèšã®åäœ
ã¹ããããå³ã¡ã
(a) æšæºããŒã¯ã®åºåã«åèšè¿äŒŒåå€å¹
ã®0.25ã
0.5åã«çžåœãã枬å®ç¹ééãå®ããã¹ãã¯ã
ã«ã®åæ£ãåäžã§ãªãå Žåã«ã枬å®ç¹ééãå±
æã¹ãã¯ãã«åæ£ã«æ¯äŸãããæéã®é 次ã®æž¬
å®ç¹ééåãå®ããã¹ãããïŒ
(b) åèšã®æž¬å®ç¹ééåã«åŸã€ãŠéãæ¢ç¥ã®åèš
èŒæ£çšè©Šæã®èŒæ£ã¹ãã¯ãã«ãå®ããã¹ãã
ãïŒ
(c) ãã®ããã«ããŠæ±ããæšæºããŒã¯ãåèšæšæº
ããŒã¯ã®å¹
å
šäœã«äºã€ãŠçŽç·çã«å€åãããã
ã¯ã°ã©ãŠã³ãä¿¡å·ã«å¯ŸããŠè£æ£ããã¹ãããïŒ
(d) ãã®ããã«ããŠè£æ£ããæšæºããŒã¯ã®äžå¿ã
å®ããäžå¿ããã®äžå¿ãšäžèŽãããã®æšæºããŒ
ã¯ãšããŒã¯ãæããç¹ã§ã¯äžèŽãããã圢ç¶ã
ã¬ãŠã¹æ²ç·ã®è² ã®äºæ¬¡å°é¢æ°ã«é¡äŒŒããåå€å¹
1 In a method in which the peak position to be formed during quantitative analysis of a multi-component sample identifies the relevant component, and the surface area of the peak provides a quantitative measure of this component, the peak spectrum is processed using a digital calculation device. The following operating steps are carried out sequentially under the control of a signal corresponding to the approximate position in the spectrum and the approximate half-width of the standard peak generated by the calibration sample, namely: (a) applying said approximate half-width to the area of the standard peak; 0.25~
(b) determining a measurement point spacing corresponding to 0.5 times the measurement point spacing, and determining a finite sequential measurement point spacing sequence that makes the measurement point spacing proportional to the local spectral dispersion if the spectral dispersion is not uniform; (b) said measurement point spacing; (c) comparing the standard peak thus determined with respect to a background signal that varies linearly over the width of the standard peak; (d) The center of the standard peak corrected in this way is determined, and the center coincides with this center, and the point with the peak coincides with this standard peak, but the shape is the negative square of the Gaussian curve. Similar to the second derivative, half-width
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56182022A JPS5883260A (en) | 1981-11-12 | 1981-11-12 | Filler for liquid chromatography |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56182022A JPS5883260A (en) | 1981-11-12 | 1981-11-12 | Filler for liquid chromatography |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5883260A JPS5883260A (en) | 1983-05-19 |
JPH0151779B2 true JPH0151779B2 (en) | 1989-11-06 |
Family
ID=16110967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56182022A Granted JPS5883260A (en) | 1981-11-12 | 1981-11-12 | Filler for liquid chromatography |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5883260A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115487543B (en) * | 2022-10-18 | 2023-06-20 | æ²³åå€§åŠ | Single-column two-phase liquid chromatography monolithic column and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5013525A (en) * | 1973-05-01 | 1975-02-13 | ||
JPS54103396A (en) * | 1978-01-31 | 1979-08-14 | Sekisui Chemical Co Ltd | Bulking agent for liquid chromatograph |
-
1981
- 1981-11-12 JP JP56182022A patent/JPS5883260A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5013525A (en) * | 1973-05-01 | 1975-02-13 | ||
JPS54103396A (en) * | 1978-01-31 | 1979-08-14 | Sekisui Chemical Co Ltd | Bulking agent for liquid chromatograph |
Also Published As
Publication number | Publication date |
---|---|
JPS5883260A (en) | 1983-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sanbe et al. | Restricted access media-molecularly imprinted polymer for propranolol and its application to direct injection analysis of β-blockers in biological fluids | |
Andersson et al. | A highly selective solid phase extraction sorbent for pre-concentration of sameridine made by molecular imprinting | |
Sajonz et al. | Study of the thermodynamics and mass transfer kinetics of two enantiomers on a polymeric imprinted stationary phase | |
Hoshina et al. | Molecularly imprinted polymers for simultaneous determination of antiepileptics in river water samples by liquid chromatographyâtandem mass spectrometry | |
Holdšvendová et al. | Methacrylate monolithic columns for capillary liquid chromatography polymerized using ammonium peroxodisulfate as initiator | |
JP4109418B2 (en) | New chromatography equipment | |
JP6733900B2 (en) | Separation carrier, method for producing separation carrier, column, and device for liquid chromatography or solid phase extraction | |
EP0534016A1 (en) | Liquid chromatographic matrices and liquid chromatography using same | |
SU1311631A3 (en) | Tip for liquid chromatography | |
JP2018189449A (en) | Separation method and analysis method | |
Zhu et al. | Development and characterization of molecularly imprinted polymer microspheres for the selective detection of kaempferol in traditional Chinese medicines | |
JP3927322B2 (en) | Method for producing packing material for liquid chromatography | |
JPH0151779B2 (en) | ||
Klein et al. | Peculiarities of polyacrylamide analysis by aqueous GPC | |
JP2007057526A (en) | Method for analyzing low-molecular-weight compound in sample containing water-soluble polymer and low-molecular-weight compound | |
Makan et al. | Field Flow Fractionation for the Size, Molar Mass, and Gel Content Analysis of Emulsion Polymers for WaterâBased Coatings | |
WO2007013651A2 (en) | Method for analyzing low molecular weight compound in sample containing water-soluble polymer and low molecular weight compound | |
US5183604A (en) | Size separation of particles contained within a material by the use of nonaqueous hydrodynamic chromatography | |
JP4268730B2 (en) | Method for producing packing material for liquid chromatography | |
JPS5888657A (en) | Filler used for liquid chromatography | |
Van Doremaele et al. | Chemical composition distribution of styreneâmethyl acrylate emulsion copolymers | |
JancÌo et al. | Liquid chromatography of polymer mixtures applying combination of exclusion and full adsorption mechanisms. I. Analysis of polystyrene in its mixture with polymethylmethacrylate single column/single eluent approach | |
JPH05133947A (en) | Carrier for liquid chromatography and method for liquid chromatography using carrier | |
Feng et al. | Rapid separation and screening of mycophenolate mofetil and mycophenolic acid with a novel (vinyl ester) resin molecular imprinted monolithic column | |
JP4037537B2 (en) | Packing for liquid chromatography |